Already registered? Need to register? Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
Most viewed
Most viewed

WOSCOPS analysis: Translating to guidelines

A new analysis of WOSCOPS (West of Scotland Coronary Prevention Study) showed that treating primary prevention patients with high LDL cholesterol has long-term mortality benefits.

Lead author Dr Antonio Vallejo-Vaz discusses this analysis with Prof Kausik RayWatch the Video
Prof Kausik Ray highlights the key take home messagesWatch the Video

News From the 7th PCSK9 Forum Expert Meeting, Barcelona, Spain

An update on cardiovascular disease, depression and adherence
David Hare

Novel approaches to LDL cholesterol lowering: Small interfering RNA (siRNA)
A background to siRNA: Pushkal Garg, Alnylam
Listen to the Webcast
An update on inclisiran: Kausik Ray
Listen to the Webcast

From the Editors

Depression, Cardiovascular Disease and AdherenceDepression, Cardiovascular Disease and Adherence

David Hare
Samia R Toukhsati

This editorial discusses the interrelationship between cardiovascular disease and depression and poses the question: Is depression a key modulator of patient adherence and clinical outcome?

Read the article